Congress

The Readout Elaine Chen

STAT Plus: Roche looks to have a competitive GLP-1 drug

Politics John Wilkerson

STAT Plus: The effort to reform physician pay is set to pit primary care docs against highly paid specialists

D.C. Diagnosis Sarah Owermohle

STAT Plus: The pharmaceutical industry keeps losing Washington friends

Politics Rachel Cohrs Zhang

STAT Plus: Drugmakers are losing crucial friends on Capitol Hill

Biotech John Wilkerson

STAT Plus: Report shows U.S. biotechs are wary of Chinese partnerships due to looming BIOSECURE Act

First Opinion Dick Durbin and Lina M. Khan

Senate, FTC cracking down on pharma patent shenanigans

Politics John Wilkerson

STAT Plus: How U.S. responses to public health emergencies could be hamstrung by the Supreme Court

The Readout Meghana Keshavan

STAT Plus: Will Medicare finally begin covering weight loss drugs like Zepbound and Wegovy?

Politics Rachel Cohrs Zhang, John Wilkerson, and Lizzy Lawrence

STAT Plus: House panel passes bills to expand Medicare obesity drug coverage, cancer screening

Politics Rachel Cohrs Zhang

STAT Plus: House panel proposes new strategy for Medicare to cover weight loss drugs Wegovy, Zepbound

First Opinion Podcast Patrick Skerrett

Rep. Diana DeGette on why reproductive freedom must be protected

D.C. Diagnosis Sarah Owermohle

STAT Plus: Senators push Medicare for a PET scan pay bump

First Opinion Diana DeGette

Two years since Dobbs, reproductive freedom must be protected from assault

Exclusive John Wilkerson and Rachel Cohrs Zhang

STAT Plus: House panel weighs new plan for Medicare coverage of Wegovy, cancer blood tests

D.C. Diagnosis Sarah Owermohle

STAT Plus: A new era for NIH

Politics Sarah Owermohle

STAT Plus: With sweeping NIH reform on the table, GOP previews new era of research scrutiny

Politics Rachel Cohrs Zhang

STAT Plus: Novo Nordisk CEO agrees to Bernie Sanders’ demand to testify on Ozempic, Wegovy prices

D.C. Diagnosis Rachel Cohrs Zhang

STAT Plus: Does Sanders have the votes to subpoena a Novo exec?

Politics Nicholas Florko

STAT Plus: Senators slam the FDA’s new vape enforcement plan: ‘What in the hell have you been waiting for?’

The Readout Elaine Chen

STAT Plus: What do Parkinson’s and obesity have in common?

D.C. Diagnosis Sarah Owermohle

FDA says it’s getting serious about illegal vapes. It’s still likely to get a tongue lashing.

Politics Sarah Owermohle

STAT Plus: House Republicans press for new guardrails on ‘gain-of-function’ research by NIH

Politics Rachel Cohrs Zhang and Elaine Chen

STAT Plus: Bernie Sanders calls vote to subpoena Novo Nordisk U.S. head over Ozempic, Wegovy prices

The Readout Meghana Keshavan

The biotech news you missed from the weekend

First Opinion Joe and Courtney Dion

Curing rare childhood diseases will falter unless Congress steps up

Biotech Jonathan Wosen and Meghana Keshavan

STAT Plus: At BIO, signs Congress’ tough stance on China is chilling biotech relationships

First Opinion Tom Daschle and Kathleen G. Sebelius

Close a regulatory loophole in the ACA to provide vaccine access for all Americans

Politics Sarah Owermohle

STAT Plus: Senators tussle over abortion policy against the backdrop of a presidential campaign

Politics Sarah Owermohle

STAT Plus: Anthony Fauci, facing GOP accusers, says debate on Covid origins has been ‘seriously distorted’